Financial Perspectives, Inc Astrazeneca PLC Transaction History
Financial Perspectives, Inc
- $298 Billion
- Q4 2024
A detailed history of Financial Perspectives, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Financial Perspectives, Inc holds 1,863 shares of AZN stock, worth $140,935. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,863
Previous 1,785
4.37%
Holding current value
$140,935
Previous $139 Million
12.23%
% of portfolio
0.04%
Previous 0.05%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.57 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.1 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.84 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.8 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.82 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...